BMC Musculoskeletal Disorders (Jan 2011)

Hyperadiponectinemia enhances bone formation in mice

  • Yoshida Tatsuhiro,
  • Mitsui Akiko,
  • Wada Nobuhiko,
  • Hashinaga Toshihiko,
  • Yuan Xiaohong,
  • Otabe Shuichi,
  • shirachi Isao,
  • Fukushima Nobuhiro,
  • Gotoh Masafumi,
  • Mitsui Yasuhiro,
  • Yoshida Shiro,
  • Yamada Kentaro,
  • Nagata Kensei

DOI
https://doi.org/10.1186/1471-2474-12-18
Journal volume & issue
Vol. 12, no. 1
p. 18

Abstract

Read online

Abstract Background There is growing evidence that adiponectin, a physiologically active polypeptide secreted by adipocytes, controls not only adipose tissue but also bone metabolism. However, a role for adiponectin in bone development remains controversial. Methods We therefore investigated the endocrine effects of adiponectin on bone metabolism using 12-week-old male transgenic (Ad-Tg) mice with significant hyperadiponectinemia overexpressing human full-length adiponectin in the liver. Results In Ad-Tg mice, the serum level of osteocalcin was significantly increased, but the levels of RANKL, osteoprotegerin, and TRAP5b were not. Bone mass was significantly greater in Ad-Tg mice with increased bone formation. In contrast, bone resorption parameters including the number of osteoclasts and eroded surface area did not differ between Ad-Tg and their littermates. Conclusions These findings demonstrate that hyperadiponectinemia enhances bone formation in mice.